Clinical Trial - Analyzing Participation Experiences Of Amyotrophic Lateral Sclerosis Patients

Clinical trial participation has always been substantially skewed toward certain demographic groups. However, there has been little study on whether trial qualities impact participation in either a positive or negative way. The goal of this research is to identify the characteristics that consistently restrict patients' ability to participate in or complete a trial in which they were initially interested. This data will be analyzed via a number of demographic lenses in order to find trends that could benefit future ALS sufferers.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Conditions

ALS Amyotrophic Lateral Sclerosis Central Nervous System Diseases Metabolic Diseases Motor Neuron Disease Nervous System Diseases Neurodegenerative Diseases Neuromuscular Diseases Nutritional and Metabolic Diseases Proteostasis Deficiencies Spinal Cord Diseases TDP-43 Proteinopathies

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Lives in the United States
Is 18+ years old
Participant has a diagnosis of Amyotrophic Lateral Sclerosis (ALS)
Participant has enrolled in an interventional clinical for ALS (self-reported)

Exclusion criteria

Inability to perform regular electronic reporting
Patient does not understand, sign, and return consent form
No diagnosis of Amyotrophic Lateral Sclerosis (ALS) confirmed

Treatment and study plan

Primary outcomes

Number of patient decides to enroll in clinical trial

Time frame: 3 months
Rate of patients who remain in clinical trial to trial completion

Time frame: 12 months

Study contacts

Contact information is provided by the study sponsor or research team.

Michael B Gill

CONTACT

https://www.withpower.com/[email protected]

415-900-4227

Sponsors and collaborators

Lead sponsor

Power Life Sciences Inc.

Industry

Registry information

Official study title

In Depth Observational Clinical Trial - Analyzing Participation Experiences Of Amyotrophic Lateral Sclerosis Patients

Important dates

Study start: 2024
Primary completion: 2025
Study completion: 2026
First posted: Jun 21, 2022
Registry last updated: Jan 2, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Not Yet Recruiting